Skip to content
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文（繁體）
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Language
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
A multicentre NCRI phase II st...
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Permanent link
A multicentre NCRI phase II study of hypofractionated conformal radiotherapy with concurrent gemcitabine in muscle-invasive bladder cancer
Bibliographic Details
Main Authors:
Choudhury, A
,
Swindell, R
,
Logue, J
,
Kiltie, A
,
Clarke, N
,
Cowan, R
Format:
Conference item
Published:
2010
Holdings
Description
Similar Items
Staff View
Similar Items
Phase II study of conformal hypofractionated radiotherapy with concurrent gemcitabine in muscle-invasive bladder cancer.
by: Choudhury, A, et al.
Published: (2011)
Gemcitabine as a Chemoradiosensitiser in Bladder Cancer
by: Kerr, M, et al.
Published: (2012)
Utility of bladder-sparing therapy vs radical cystectomy for muscle-invasive bladder cancer
by: Efstathiou, J, et al.
Published: (2018)
Predictive Biomarkers for Gemcitabine as a Chemoradiosensitizer in Bladder Cancer
by: Kerr, M, et al.
Published: (2012)
Treatment of Breast and Prostate Cancer by Hypofractionated Radiotherapy: Potential Risks and Benefits
by: Ray, K, et al.
Published: (2015)